Healthcare spending in the United Kingdom (UK) as a share of the gross domestic product (GDP) has increased since 1990, when it was 5.1 percent. By 2023, healthcare expenditure in the UK amounted 10.9 percent of the GDP. Health expenditure in the UK compared to Europe  In comparison to other European countries in 2022, the UK ranked fifth highest in terms of healthcare spending as a share of the GDP. Top of the list was Germany, which spent 12.7 percent of its GDP on healthcare in this year. This was followed by France and Austria, which spent 11.9 percent and 11.4 percent on health, respectively. Performance of the NHS in the UK  Individuals in the UK still regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. Although waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.   

In 2023, the annual spending on public healthcare in the United Kingdom (UK) accounted for 8.9 percent of GDP. This is a significant decrease from 10.1 percent in 2020 and 2021, which were the highest shares in the reported time period. Total spending on health in the UK In total, approximately 282 billion British pounds were spent on healthcare in the UK in 2022. Although, spending as a share of GDP decreased from 2009 to 2019, the total spending on health has continued to increase. Broken down by function, the UK government spent almost 139 billion pounds on curative/rehabilitative care. Performance of the NHS in the UK Individuals in the UK still regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. However, waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.

United Kingdom UK: Current Health Expenditure: % of GDP data was reported at 9.877 % in 2015. This records an increase from the previous number of 9.799 % for 2014. United Kingdom UK: Current Health Expenditure: % of GDP data is updated yearly, averaging 7.615 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 9.877 % in 2015 and a record low of 6.012 % in 2000. United Kingdom UK: Current Health Expenditure: % of GDP data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s UK – Table UK.World Bank: Health Statistics. Level of current health expenditure expressed as a percentage of GDP. Estimates of current health expenditures include healthcare goods and services consumed during each year. This indicator does not include capital health expenditures such as buildings, machinery, IT and stocks of vaccines for emergency or outbreaks.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

Healthcare spending in the United Kingdom (UK) has gradually increased since 2000 when it amounted to 78.5 billion British pounds. By 2021, healthcare expenditure in the UKreached a maximum of over 244 billion British pounds. This was an increase of approximately two billion British pounds on the previous year's healthcare spending. In 2023, this figure stood at almost 230 billion British pounds. Health expenditure in the UK compared to Europe In 2023, the UK spent almost 11 percent of its GDP on healthcare. In comparison to other European countries, this ranked the UK fifth in terms of health expenditure. At the op of the list was Switzerland, which spent 12 percent of its GDP on healthcare that year.  Performance of the NHS in the UK The majority of surveyed individuals in the UK regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. Although waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.

United Kingdom UK: Domestic General Government Health Expenditure: % of GDP data was reported at 7.936 % in 2015. This records an increase from the previous number of 7.870 % for 2014. United Kingdom UK: Domestic General Government Health Expenditure: % of GDP data is updated yearly, averaging 6.382 % from Dec 2000 (Median) to 2015, with 16 observations. The data reached an all-time high of 7.936 % in 2015 and a record low of 4.917 % in 2000. United Kingdom UK: Domestic General Government Health Expenditure: % of GDP data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s UK – Table UK.World Bank: Health Statistics. Public expenditure on health from domestic sources as a share of the economy as measured by GDP.; ; World Health Organization Global Health Expenditure database (http://apps.who.int/nha/database).; Weighted average;

The government of the United Kingdom spent over 221 billion British pounds on health in 2023/24, compared with 221 billion pounds in 2022/23.

In 2023/24, health spending in the United Kingdom was 3,268 British pounds per capita, ranging from 3,975 pounds per capita in London, to 2,899 pounds per capita in East England.

The healthcare spending growth rate in the United Kingdom (UK) has experienced fluctuations since 1998. Then, the healthcare spending growth rate was 5.7 percent and by 2021 the healthcare spending growth was highest at 9.7 percent. 2003 saw the second highest healthcare spending growth rate at 8.6 percent, while in 2013, the growth rate was only one percent, a significant decrease from the preceding years.

Health expenditure in the UK compared to Europe

In 2019, the UK spent just 10.3 percent of its GDP on healthcare. In comparison to other European countries, this ranked the UK seventh in terms of health expenditure in 2019. Top of the list was Switzerland, which spent 12.1 percent of its’ GDP on healthcare in this year.

Consequences from low spending growth?

The majority of surveyed individuals in the UK, regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. Although waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.

Total healthcare expenditure in the UK as a percentage of GDP.

Healthcare spending in the United Kingdom (UK) in both sectors has increased since 1997, although spending in the public sector has increased at a faster rate. By 2018, public healthcare expenditure in the UK stood at to 149.5 billion British pounds, compared to 34.5 billion British pounds in the private sector.

Health expenditure in the UK compared to Europe 

In 2019, the UK spent just over ten percent of its GDP on healthcare. In comparison to other European countries, this ranked the UK seventh in terms of health expenditure in 2019. Top of the list was Switzerland, which spent 12.1 percent of its’ GDP on healthcare in this year.  

Performance of the public health sector in UK 

The majority of people questioned in a survey in the UK, regard the NHS as a world class health service and remain happy with the high level of care provided by the organization. Although waiting times have been getting worse in the A&E department over the years. The NHS has been falling behind the target that 95 percent of patients should be seen within four hours of arrival. As a result, the primary reasons for dissatisfaction with the NHS among the public are the length of time required to get a GP or hospital appointment and the lack of staff.   

This statistic displays the annual public healthcare spending in the United Kingdom from 2000 to 2023. The total public healthcare spending increased over the period concerned to approximately 3,409 British pounds per capita in 2022, the highest in the provided time interval, before slightly falling to 3,392 British pounds in 2023.

In 2022, spending on private/voluntary healthcare accounted for 0.52 percent of GDP. The share has generally increased since 2000 when private/voluntary healthcare spending was just 0.48 percent of GDP. This statistic displays the annual spending on private (voluntary) healthcare as a share of GDP in the United Kingdom from 2000 to 2022.

Among OECD member countries, the United States had the highest percentage of gross domestic product spent on health care as of 2023. The U.S. spent nearly 16 percent of its GDP on health care services. Germany, France and Japan followed the U.S. with distinctly smaller percentages. The United States had both significantly higher private and public spending on health compared with other developed countries. Why compare OECD countries?OECD stands for Organization for Economic Co-operation and Development. It is an economic organization consisting of 38 members, mostly high-income countries and committed to democratic principles and market economy. This makes OECD statistics more comparable than statistics of developed and undeveloped countries. Health economics is an important matter for the OECD, even more since increasing health costs and an aging population have become an issue for many developed countries. Health costs in the U.S.  A higher GDP share spent on health care does not automatically lead to a better functioning health system. In the case of the U.S., high spending is mainly because of higher costs and prices, not due to higher utilization. For example, physicians’ salaries are much higher in the U.S. than in other comparable countries. A doctor in the U.S. earns almost twice as much as the average physician in Germany. Pharmaceutical spending per capita is also distinctly higher in the United States. Furthermore, the U.S. also spends more on health administrative costs compare to other wealthy countries.

Gross value added (GVA) in the human health and social work sector was 189 billion British pounds in 2024, compared with 184 billion pounds in 2023.

The majority of healthcare expenditure in the United Kingdom is publicly funded through the National Health Service, amounting to 230.5 billion British pounds in 2022. This statistic shows the public or government-financed healthcare expenditure in the United Kingdom from 1997 to 2022.

These contain my projections of Philippine health insurance expenditures from 2010 to 2014. The determinants of health expenditure growth are size and structure of the population, real growth rate, and GDP growth rate.

The total expenditure on health as a share of gross domestic product (GDP) in Ireland amounted to just 6.6 percent in 2023, an increase from the previous year. Between 2009 and 2013, spending on health in Ireland was over ten percent of its GDP before declining again since 2014. Health expenditure in Ireland compared to Europe In comparison to other European countries in 2022, Ireland ranked considerably low in terms of health spending as a share of GDP. At the top of the list was Germany, which spent 12.7 percent of its GDP on healthcare in this year.  The UK, Ireland’s closest neighbor, spent 11.3 percent of its GDP on health. Trend of healthcare workers in Ireland In 2022, there were over 82.1 thousand individuals employed at hospitals in Ireland, since the year 2000 this figure has increased by nearly 32 thousand. Similarly, in the period since 2000, the number of general practitioners in Ireland has more than doubled to some 4.3 thousand in 2021.

Snapshot img

Predictive Presymptomatic Testing Market Size 2024-2028

The predictive presymptomatic testing market size is forecast to increase by USD 2.59 billion, at a CAGR of 10.03% between 2023 and 2028. The global Predictive Presymptomatic Testing market is experiencing significant growth due to several key factors. Firstly, the increasing healthcare spending worldwide is driving demand for advanced diagnostic tools and genetic testing. Secondly, the rise in awareness toward early screening of genetic disorders has led to an increasing demand for predictive presymptomatic testing. This testing allows individuals with a family history of certain genetic disorders to identify their risk and take preventative measures before symptoms appear. Genetic counseling plays a crucial role in this process, providing essential information and support to individuals and families. As a result, the market for predictive presymptomatic testing is expected to grow steadily in the coming years.

What will be the Size of the Market During the Forecast Period?

For More Highlights About this Report, Request Free Sample

Market Dynamic

In the realm of wearable technology, wrist watches and jewelry have evolved beyond mere accessories into functional devices that monitor health risks and track sleep patterns. Innovations like augmented reality and virtual reality are reshaping how we interact with information and environments, enhancing experiences through speech recognition and immersive visuals. Devices such as Google Glass integrate seamlessly into daily life, offering real-time data and enhancing safety with features like camera integration for recording events. For active lifestyles, wearables like heart rate monitors and shoes equipped with sensors provide insights into exercise intensity and performance. The development of coexistence testing ensures these technologies work harmoniously without interference, akin to how pigeons navigate without colliding in crowded skies. From tracking steps to enhancing productivity, wearable technology continues to blur the lines between fashion and functionality, promising a future where innovation meets everyday convenience.

Key Market Driver

The increasing healthcare spending worldwide is one of the key drivers supporting the predictive presymptomatic testing market growth. The governments of developed nations such as the US, Germany, and others have increased their healthcare expenditure in recent years. Through the support of the governments and a surge in healthcare expenditures, global private and public healthcare facilities and not-for-profit organizations (NPOs) are able to provide their services to patients. According to The World Health Organization (WHO), global spending on healthcare continually rose between 2000 and 2018 and reached USD 8.3 trillion or 10% of global GDP. Thus, the increasing expenditure in the global healthcare sector and the increase in government aid to healthcare providers will boost the growth of the global predictive presymptomatic testing market during the forecast period.

Significant Market Trends

The growing prevalence of genetic diseases is one of the key predictive presymptomatic testing market trends that is contributing to the market growth. According to the Centers for Disease Control and Prevention (CDC), in the US, more than 1.6 million patients are getting diagnosed with cancer every year, with almost 600,000 fatalities. The incidence of genetic disorders is gradually increasing. Moreover, the increasing incidence of chronic diseases and genetic disorders leads researchers and scientists to opt for predictive presymptomatic testing for diagnosing and treating patients. Researchers are increasingly focusing on predictive presymptomatic testing due to its high impact on diagnosing and treating diseases using gene therapy and recombinant vaccines. Hence, an increase in the prevalence of genetic disorders is expected to drive the growth of the global predictive presymptomatic testing market during the forecast period.

Major Market Challenge

The high cost of tests is one of the factors hindering the predictive presymptomatic testing market growth. For instance, in 2019, the per capita healthcare expenditure was USD 7,138 in Switzerland, USD 6,748 in Norway, and USD 6,731 in Germany. Additionally, in developing countries such as India, China, and others, due to a lack of resources and low per capita income, patients are unable to avail themselves of predictive presymptomatic test kits. The absence of proper healthcare infrastructure and less amount of government aid received in the form of medical expense reimbursement further acts as a challenge for the patients in these countries. Thus, the global per capita healthcare cost is expected to increase during the forecast period. This will negatively affect the growth of the global predictive presymptomatic testing market during the forecast p

This statistic displays the share of GDP spent on the National Health Service (NHS) in the United Kingdom, forecast from 2015/16 to 2030/31. By 2030/31 the share of GDP to be spent on the NHS is expected to decrease to 7.1 percent.

The majority of healthcare expenditure in the United Kingdom is publicly funded through the NHS, though private household out-of-pocket and voluntary health insurance spending amounted to 46.4 billion British pounds in 2022. This statistic shows the private sector (including out-of-pocket and voluntary health insurance schemes) healthcare expenditure in the United Kingdom from 1997 to 2022.